Epicore Biosystems Expands Series B to $32M to Power Global Growth of Sweat-Sensing Wearable Technology
Summary
The follow-on round includes new backing from a San Francisco-based investor and marquee angel investors, along with continued support from and .This latest investment follows Epicores initial $26M Series B raise led by the Steele Foundation for Hope, and positions the company to accelerate its global expansion and scale next-generation sweat-sensing technologies.Epicore wearables measure sweat composition and fluid losses, as well as important physiological markers like skin temperature, motion and thermal flux to detect early signs of fatigue, heat exhaustion and performance. The impact of its flagship product, Connected Hydration, has been detailed for industrial workers and athletes, most recently in , and piloted at major professional sports activation events like the 2025 Super Bowl. "Epicores biosensing technologies deliver precisely what large industries and enterprises need science-backed digital tools to protect workers, boost productivity and improve lives," said Michael Edelhart, managing director of Joyance Partners. "Epicores growing list of enterprise partners includes Chevron, PepsiCo, Gatorade, United Airlines, Bechtel, Denka, Nitto, the U.S. Air Force, the Office of Naval Research and the U.S. Army. Their clinically validated biowearable solutions and cloud analytics are deployed globally and licensed by leading Fortune 1000 companies, the Department of Defense, and the National Institute of Health.